+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Conjugate Vaccine Market by Product Type (Hib Conjugate Vaccine, Meningococcal Conjugate Vaccine, Pneumococcal Conjugate Vaccine), Distribution Channel (Offline, Online), Technology, End User - Global Forecast 2025-2030- Product Image
Conjugate Vaccine Market by Product Type (Hib Conjugate Vaccine, Meningococcal Conjugate Vaccine, Pneumococcal Conjugate Vaccine), Distribution Channel (Offline, Online), Technology, End User - Global Forecast 2025-2030- Product Image
Sale

Conjugate Vaccine Market by Product Type (Hib Conjugate Vaccine, Meningococcal Conjugate Vaccine, Pneumococcal Conjugate Vaccine), Distribution Channel (Offline, Online), Technology, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 186 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4896495
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The conjugate vaccine market is rapidly evolving due to emerging infectious threats, regulatory enhancements, and innovations in vaccine technology. Senior executives evaluating investment or operational decisions within this sector require a concise and up-to-date overview of the key trends, strategic imperatives, and actionable insights shaping the market’s competitive dynamics.

Market Snapshot: Conjugate Vaccine Market Overview

The conjugate vaccine market grew from USD 43.92 billion in 2024 to USD 48.92 billion in 2025. It is expected to continue growing at a CAGR of 10.85%, reaching USD 81.51 billion by 2030. This growth is supported by advancements in carrier protein platforms, changing disease patterns, and ongoing healthcare innovation. Companies across the pharmaceutical value chain are adapting to evolving regulatory landscapes, heightened public-private collaborations, and increasing demand for flexible production capacity and robust supply chains.

Scope & Segmentation

This report offers comprehensive coverage and segmentation of the conjugate vaccine market. Areas of analysis include:

  • Product Types: Hib conjugate vaccine, meningococcal conjugate vaccine, pneumococcal conjugate vaccine
  • Distribution Channels: Offline, online
  • Technologies: Crm197, Dt, Tt
  • End Users: Clinics, hospitals
  • Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Companies Analyzed: Biological E. Limited, Pfizer Inc., GlaxoSmithKline plc, Sanofi S.A., Merck & Co., Inc., Serum Institute of India Pvt. Ltd., Bharat Biotech International Ltd., Panacea Biotec Ltd., SK bioscience Co., Ltd., Bavarian Nordic A/S

Key Takeaways for Decision-Makers

  • Carrier protein innovation is reshaping immunogenicity profiles and reducing manufacturing complexity, creating new product segment opportunities.
  • Technological upgrades in adjuvant systems and digital cold-chain tools are strengthening vaccine efficacy and distribution efficiency.
  • Market growth is accelerated by cross-sector partnerships, combining resources to drive immunization programs in both developed and underserved regions.
  • Adaptive regulatory frameworks are expediting product approvals, enabling faster responses to emerging public health demands.
  • Supply chain resilience is being augmented by localized production, alternative sourcing, and traceability, addressing vulnerabilities posed by geopolitical and tariff-related disruptions.
  • Segmented strategy is required: clinics prioritize routine pediatric immunization, while hospitals focus on adult and immunocompromised populations with high-valency vaccines.

Tariff Impact: U.S. Trade Policy and Supply Chain Implications

Recent U.S. tariff adjustments have influenced vaccine supply chains, increasing input costs for manufacturers dependent on imported materials. Strategic responses include renegotiating supplier contracts, accelerating localization efforts, and investing in domestic production to stabilize costs and ensure supply continuity. Companies are also diversifying manufacturing footprints and engaging with policymakers to manage risks in both established and emerging markets.

Methodology & Data Sources

This analysis uses a blend of secondary research, including peer-reviewed literature and market filings, with primary interviews from vaccine developers, supply chain experts, and healthcare professionals. Quantitative data are validated through triangulation across multiple sources. External subject matter peer review ensures the robustness, transparency, and objectivity of all findings.

Why This Report Matters

  • Supports timely decision-making by providing segmented insights across products, channels, technologies, and regions critical for market entry, expansion, or risk management.
  • Equips leaders with evidence-based guidance on technological adoption, strategic alliances, and supply continuity strategies in a shifting global landscape.

Conclusion

The conjugate vaccine market is experiencing significant transformation driven by innovation, regulation, and collaboration. Informed strategies, early stakeholder engagement, and targeted investment are essential for capitalizing on market opportunities and sustaining competitive advantage within this evolving sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing adoption of novel site-specific conjugation techniques to improve vaccine consistency and safety
5.2. Expansion of pneumococcal conjugate vaccine programs in low and middle income countries through Gavi funding
5.3. Development of multivalent meningococcal conjugate vaccines targeting emerging serogroups W and X to broaden protection
5.4. Collaborative partnerships between biotech firms and pharma giants accelerating next generation conjugate vaccine pipelines
5.5. Implementation of advanced carrier protein alternatives to reduce immunogenic interference in multivalent formulations
5.6. Integration of pneumococcal conjugate vaccination into adult immunization schedules to address aging population risks
5.7. Regulatory approval trends for biosimilar conjugate vaccines shaping competitive landscape and pricing strategies
5.8. Technological advancements in cold chain and thermostability formulations enhancing conjugate vaccine distribution efficiency
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Conjugate Vaccine Market, by Product Type
8.1. Introduction
8.2. Hib Conjugate Vaccine
8.3. Meningococcal Conjugate Vaccine
8.4. Pneumococcal Conjugate Vaccine
9. Conjugate Vaccine Market, by Distribution Channel
9.1. Introduction
9.2. Offline
9.3. Online
10. Conjugate Vaccine Market, by Technology
10.1. Introduction
10.2. Crm197
10.3. Dt
10.4. Tt
11. Conjugate Vaccine Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Hospitals
12. Americas Conjugate Vaccine Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Conjugate Vaccine Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Conjugate Vaccine Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Biological E. Limited
15.3.2. Pfizer Inc.
15.3.3. GlaxoSmithKline plc
15.3.4. Sanofi S.A.
15.3.5. Merck & Co., Inc.
15.3.6. Serum Institute of India Pvt. Ltd.
15.3.7. Bharat Biotech International Ltd.
15.3.8. Panacea Biotec Ltd.
15.3.9. SK bioscience Co., Ltd.
15.3.10. Bavarian Nordic A/S
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. CONJUGATE VACCINE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CONJUGATE VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS CONJUGATE VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS CONJUGATE VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES CONJUGATE VACCINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES CONJUGATE VACCINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. CONJUGATE VACCINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. CONJUGATE VACCINE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. CONJUGATE VACCINE MARKET: RESEARCHAI
FIGURE 24. CONJUGATE VACCINE MARKET: RESEARCHSTATISTICS
FIGURE 25. CONJUGATE VACCINE MARKET: RESEARCHCONTACTS
FIGURE 26. CONJUGATE VACCINE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CONJUGATE VACCINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CONJUGATE VACCINE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CONJUGATE VACCINE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY HIB CONJUGATE VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY HIB CONJUGATE VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY MENINGOCOCCAL CONJUGATE VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY MENINGOCOCCAL CONJUGATE VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PNEUMOCOCCAL CONJUGATE VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PNEUMOCOCCAL CONJUGATE VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY OFFLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY OFFLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY ONLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY CRM197, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY CRM197, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY DT, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY DT, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY TT, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY TT, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. AMERICAS CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 38. AMERICAS CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 39. AMERICAS CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 40. AMERICAS CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 41. AMERICAS CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 42. AMERICAS CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 43. AMERICAS CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 44. AMERICAS CONJUGATE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 45. AMERICAS CONJUGATE VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 46. AMERICAS CONJUGATE VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 47. UNITED STATES CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 48. UNITED STATES CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 49. UNITED STATES CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 50. UNITED STATES CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 51. UNITED STATES CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 52. UNITED STATES CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 53. UNITED STATES CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 54. UNITED STATES CONJUGATE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 55. UNITED STATES CONJUGATE VACCINE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 56. UNITED STATES CONJUGATE VACCINE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 57. CANADA CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 58. CANADA CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 59. CANADA CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 60. CANADA CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 61. CANADA CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 62. CANADA CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 63. CANADA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 64. CANADA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 65. MEXICO CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 66. MEXICO CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 67. MEXICO CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 68. MEXICO CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 69. MEXICO CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 70. MEXICO CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 71. MEXICO CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 72. MEXICO CONJUGATE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 73. BRAZIL CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 74. BRAZIL CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 75. BRAZIL CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 76. BRAZIL CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 77. BRAZIL CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 78. BRAZIL CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 79. BRAZIL CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 80. BRAZIL CONJUGATE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 81. ARGENTINA CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 82. ARGENTINA CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 83. ARGENTINA CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 84. ARGENTINA CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 85. ARGENTINA CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 86. ARGENTINA CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 87. ARGENTINA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 88. ARGENTINA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 100. UNITED KINGDOM CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 101. UNITED KINGDOM CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 102. UNITED KINGDOM CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 104. UNITED KINGDOM CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 105. UNITED KINGDOM CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. UNITED KINGDOM CONJUGATE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. GERMANY CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 108. GERMANY CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 109. GERMANY CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 110. GERMANY CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 111. GERMANY CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 112. GERMANY CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 113. GERMANY CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. GERMANY CONJUGATE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. FRANCE CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 116. FRANCE CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 117. FRANCE CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 118. FRANCE CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 119. FRANCE CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 120. FRANCE CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 121. FRANCE CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 122. FRANCE CONJUGATE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 123. RUSSIA CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 124. RUSSIA CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 125. RUSSIA CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. RUSSIA CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. RUSSIA CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 128. RUSSIA CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 129. RUSSIA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. RUSSIA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. ITALY CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 132. ITALY CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 133. ITALY CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 134. ITALY CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 135. ITALY CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 136. ITALY CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 137. ITALY CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. ITALY CONJUGATE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. SPAIN CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 140. SPAIN CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 141. SPAIN CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 142. SPAIN CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 143. SPAIN CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 144. SPAIN CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 145. SPAIN CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. SPAIN CONJUGATE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 148. UNITED ARAB EMIRATES CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 149. UNITED ARAB EMIRATES CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. UNITED ARAB EMIRATES CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. UNITED ARAB EMIRATES CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 152. UNITED ARAB EMIRATES CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 153. UNITED ARAB EMIRATES CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 154. UNITED ARAB EMIRATES CONJUGATE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 156. SAUDI ARABIA CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 158. SAUDI ARABIA CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 160. SAUDI ARABIA CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. SAUDI ARABIA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 164. SOUTH AFRICA CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. SOUTH AFRICA CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 168. SOUTH AFRICA CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. SOUTH AFRICA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. DENMARK CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 172. DENMARK CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 173. DENMARK CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 174. DENMARK CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 175. DENMARK CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 176. DENMARK CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 177. DENMARK CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. DENMARK CONJUGATE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. NETHERLANDS CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 180. NETHERLANDS CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 181. NETHERLANDS CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 182. NETHERLANDS CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 183. NETHERLANDS CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 184. NETHERLANDS CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 185. NETHERLANDS CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. NETHERLANDS CONJUGATE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. QATAR CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 188. QATAR CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 189. QATAR CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 190. QATAR CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 191. QATAR CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 192. QATAR CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 193. QATAR CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. QATAR CONJUGATE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. FINLAND CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 196. FINLAND CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 197. FINLAND CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. FINLAND CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. FINLAND CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 200. FINLAND CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 201. FINLAND CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 202. FINLAND CONJUGATE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 203. SWEDEN CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 204. SWEDEN CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 205. SWEDEN CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 206. SWEDEN CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 207. SWEDEN CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 208. SWEDEN CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 209. SWEDEN CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. SWEDEN CONJUGATE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. NIGERIA CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 212. NIGERIA CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 213. NIGERIA CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 214. NIGERIA CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 215. NIGERIA CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 216. NIGERIA CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 217. NIGERIA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. NIGERIA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. EGYPT CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 220. EGYPT CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 221. EGYPT CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 222. EGYPT CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 223. EGYPT CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 224. EGYPT CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 225. EGYPT CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. EGYPT CONJUGATE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. TURKEY CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 228. TURKEY CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 229. TURKEY CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 230. TURKEY CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 231. TURKEY CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 232. TURKEY CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 233. TURKEY CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. TURKEY CONJUGATE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. ISRAEL CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 236. ISRAEL CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 237. ISRAEL CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 238. ISRAEL CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 239. ISRAEL CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 240. ISRAEL CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 241. ISRAEL CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. ISRAEL CONJUGATE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. NORWAY CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 244. NORWAY CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 245. NORWAY CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 246. NORWAY CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 247. NORWAY CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 248. NORWAY CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 249. NORWAY CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 250. NORWAY CONJUGATE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 251. POLAND CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 252. POLAND CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 253. POLAND CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 254. POLAND CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 255. POLAND CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 256. POLAND CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 257. POLAND CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. POLAND CONJUGATE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. SWITZERLAND CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 260. SWITZERLAND CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 261. SWITZERLAND CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 262. SWITZERLAND CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 263. SWITZERLAND CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 264. SWITZERLAND CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 265. SWITZERLAND CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. SWITZERLAND CONJUGATE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 268. ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 270. ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 272. ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 273. ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 276. ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 277. CHINA CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 278. CHINA CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 279. CHINA CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 280. CHINA CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 281. CHINA CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 282. CHINA CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 283. CHINA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. CHINA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. INDIA CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 286. INDIA CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 287. INDIA CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 288. INDIA CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 289. INDIA CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 290. INDIA CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 291. INDIA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 292. INDIA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 293. JAPAN CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 294. JAPAN CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 295. JAPAN CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 296. JAPAN CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 297. JAPAN CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 298. JAPAN CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 299. JAPAN CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 300. JAPAN CONJUGATE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 301. AUSTRALIA CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 302. AUSTRALIA CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 303. AUSTRALIA CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 304. AUSTRALIA CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 305. AUSTRALIA CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 306. AUSTRALIA CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 307. AUSTRALIA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 308. AUSTRALIA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 309. SOUTH KOREA CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 310. SOUTH KOREA CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 311. SOUTH KOREA CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 312. SOUTH KOREA CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 313. SOUTH KOREA CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 314. SOUTH KOREA CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 315. SOUTH KOREA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 316. SOUTH KOREA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 317. INDONESIA CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 318. INDONESIA CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 319. INDONESIA CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 320. INDONESIA CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 321. INDONESIA CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 322. INDONESIA CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 323. INDONESIA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 324. INDONESIA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 325. THAILAND CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 326. THAILAND CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 327. THAILAND CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 328. THAILAND CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 329. THAILAND CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 330. THAILAND CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 331. THAILAND CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 332. THAILAND CONJUGATE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 333. PHILIPPINES CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 334. PHILIPPINES CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 335. PHILIPPINES CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 336. PHILIPPINES CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 337. PHILIPPINES CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 338. PHILIPPINES CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 339. PHILIPPINES CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 340. PHILIPPINES CONJUGATE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 341. MALAYSIA CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 342. MALAYSIA CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 343. MALAYSIA CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 344. MALAYSIA CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 345. MALAYSIA CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 346. MALAYSIA CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 347. MALAYSIA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 348. MALAYSIA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 349. SINGAPORE CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 350. SINGAPORE CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 351. SINGAPORE CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 352. SINGAPORE CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 353. SINGAPORE CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2

Samples

Loading
LOADING...

Companies Mentioned

  • Biological E. Limited
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • Merck & Co., Inc.
  • Serum Institute of India Pvt. Ltd.
  • Bharat Biotech International Ltd.
  • Panacea Biotec Ltd.
  • SK bioscience Co., Ltd.
  • Bavarian Nordic A/S

Table Information

Report AttributeDetails
No. of Pages186
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 48.92 Billion
Forecasted Market Value ( USD ) by 2030 $ 81.51 Billion
Compound Annual Growth Rate10.8%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Pneumococcal Vaccine Market by Vaccine Type (Conjugate Vaccine, Polysaccharide Vaccine), Age Group (Adult, Children, Geriatric), Distribution Channel, End User - Global Forecast 2025-2030 - Product Image

Pneumococcal Vaccine Market by Vaccine Type (Conjugate Vaccine, Polysaccharide Vaccine), Age Group (Adult, Children, Geriatric), Distribution Channel, End User - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Clostridium Vaccine Market by Vaccine Type (Conjugate Vaccine, Polysaccharide Vaccine, Recombinant Vaccine), Target Disease (Botulism, Gas Gangrene, Tetanus), Route Of Administration, Distribution Channel, End User - Global Forecast 2025-2030 - Product Image

Clostridium Vaccine Market by Vaccine Type (Conjugate Vaccine, Polysaccharide Vaccine, Recombinant Vaccine), Target Disease (Botulism, Gas Gangrene, Tetanus), Route Of Administration, Distribution Channel, End User - Global Forecast 2025-2030

  • Report
  • 192 Pages
  • Global
From
Conjugate Vaccines - Global Strategic Business Report - Product Image

Conjugate Vaccines - Global Strategic Business Report

  • Report
  • 271 Pages
  • Global
From
Conjugate Vaccine Market Report 2025 - Product Image

Conjugate Vaccine Market Report 2025

  • Report
  • 200 Pages
  • Global
From
H1N1 Vaccines - Global Strategic Business Report - Product Image

H1N1 Vaccines - Global Strategic Business Report

  • Report
  • 268 Pages
  • Global
From

About the Conjugate Vaccine Market

The Conjugate Vaccine market is a subset of the Vaccines market, which is composed of products designed to prevent and treat infectious diseases. Conjugate Vaccines are a type of vaccine that combines a polysaccharide antigen with a protein carrier, which helps the body to recognize the antigen and mount an immune response. These vaccines are used to protect against a variety of bacterial infections, including meningitis, pneumonia, and sepsis. Conjugate Vaccines are typically administered to infants and young children, as their immune systems are not yet fully developed and are more susceptible to certain infections. In addition, these vaccines are often used in combination with other vaccines to provide broader protection against multiple diseases. Notable companies in the Conjugate Vaccine market include GlaxoSmithKline, Merck & Co., Pfizer, Sanofi, and Novartis. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.